Skip to main content

Diagnosis, Staging and Management of Testis Cancer

  • Chapter
  • First Online:
Urologic Principles and Practice

Part of the book series: Springer Specialist Surgery Series ((SPECIALIST))

  • 1225 Accesses

Abstract

Testis cancer is the most common solid malignancy in young men. Over 90% are germ cell tumours (GCTs), sub-categorised into seminoma and non-seminoma.

Investigation of a testis mass is with ultrasound, CT imaging and tumour marker assay before surgery by radical inguinal orchidectomy if tumour is suspected. Disease localised to the scrotum is curable with surgery alone in most cases but high risk features in clinical stage I disease (CS1) predict failure in a proportion. Post-operative surveillance is appropriate for most CS1 cases with adjuvant treatment advocated for some with high risk characteristics.

Advanced disease (CS2 or greater) requires urgent treatment with combination chemotherapy, usually including bleomycin, etoposide and platinum (BEP). Post chemotherapy tumour masses are resected surgically when possible. Metastatic disease is sub-stratified into low, intermediate and high risk based on the extent and location of metastases and the post-orchidectomy level of specific tumour markers. This enables use of risk stratified treatment regimens tailored to individual patients according to their disease characteristics.

Cure is possible in most, with 5-year overall survival rates of 97% overall, although high risk NSGCT still has a mortality >50%. Reducing treatment related toxicity whilst improving outcomes is an ongoing priority in this disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 64.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 64.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. UICC. TNM classification of malignant tumours, vol. 2016. 8th ed. Hoboken: Wiley Blackwell; 2016.

    Google Scholar 

  2. https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/testicular-cancer. Cancer Research UK; 2016.

  3. Laguna MP, Albers P, Albrecht W, Algaba F, Bokemeyer C. EAU guidelines on testicular cancer; 2019. https://uroweb.org/wp-content/uploads/EAU-Guidelines-on-Testicular-Cancer-2019-1.pdf.

  4. Honecker F, Aparicio J, Berney D, Beyer J, Bokemeyer C, Cathomas R, et al. ESMO consensus conference on testicular germ cell cancer: diagnosis, treatment and follow-up. Ann Oncol. 2018;29(8):1658–86.

    Article  CAS  Google Scholar 

  5. Robinson R, Tait CD, Clarke NW, Ramani VAC. Is it safe to insert a testicular prosthesis at the time of radical orchidectomy for testis cancer: an audit of 904 men undergoing radical orchidectomy. BJU Int. 2016;117(2):249–52.

    Article  Google Scholar 

  6. Andreassen KE, Grotmol T, Cvancarova MS, Johannesen TB, Fossã SD. Risk of metachronous contralateral testicular germ cell tumors: a population-based study of 7,102 Norwegian patients (1953-2007). Int J Cancer. 2011;129(12):2867–74.

    Article  CAS  Google Scholar 

  7. Moch H, Cubilla AL, Humphrey PA, Reuter VE, Ulbright TM. The 2016 WHO classification of tumours of the urinary system and male genital organs—part a: renal, penile, and testicular tumours. Eur Urol. 2016;70(1):93–105. Available from. https://doi.org/10.1016/j.eururo.2016.02.029.

    Article  PubMed  Google Scholar 

  8. Mead G, Stenning S, Cook P. International germ cell consensus classification: a prognostic factor-based staging system for metastatic germ cell cancers. International germ cell Cancer collaborative group. J Clin Oncol. 1997;15(2):594–603.

    Article  Google Scholar 

  9. Kollmannsberger C, Tandstad T, Bedard PL, Cohn-Cedermark G, Chung PW, Jewett MA, et al. Patterns of relapse in patients with clinical stage I testicular cancer managed with active surveillance. J Clin Oncol. 2015;33(1):51–7.

    Article  Google Scholar 

  10. Daugaard G, Gundgaard MG, Mortensen MS, Agerbæk M, Holm NV, Rørth M, et al. Surveillance for stage I nonseminoma testicular cancer: outcomes and long-term follow-up in a population-based cohort. J Clin Oncol. 2014;32(34):3817–23.

    Article  Google Scholar 

  11. Cohn-Cedermark G, Stahl O, Tandstad T. Surveillance vs. adjuvant therapy of clinical stage I testicular tumors - a review and the SWENOTECA experience. Andrology. 2015;3(1):102–10.

    Article  CAS  Google Scholar 

  12. Warde P, Specht L, Horwich A, Oliver T, Panzarella T, Gospodarowicz M, et al. Prognostic factors for relapse in stage I seminoma managed by surveillance: a pooled analysis. J Clin Oncol. 2002;20(22):4448–52.

    Article  Google Scholar 

  13. Aparicio J, Maroto P, García del Muro X, Sánchez-Muñoz A, Gumà J, Margelí M, et al. Prognostic factors for relapse in stage I seminoma: a new nomogram derived from three consecutive, risk-adapted studies from the Spanish Germ Cell Cancer Group (SGCCG). Ann Oncol. 2014;25(11):2173–8.

    Article  CAS  Google Scholar 

  14. Oliver RTD, Mason MD, Mead GM, Von Der Maase H, Rustin GJS, Joffe JK, et al. Radiotherapy versus single-dose carboplatin in adjuvant treatment of stage I seminoma: a randomised trial. Lancet. 2005;366(9482):293–300.

    Article  CAS  Google Scholar 

  15. Clarke NW. Late relapse in testicular cancer. In: Stief C, Fizazi K, Evans C, editors. Medical treatment of urological malignancies: EAU/IUCD; 2016. p. 81–3.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Noel W. Clarke .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Clarke, N.W. (2020). Diagnosis, Staging and Management of Testis Cancer. In: Chapple, C., Steers, W., Evans, C. (eds) Urologic Principles and Practice. Springer Specialist Surgery Series. Springer, Cham. https://doi.org/10.1007/978-3-030-28599-9_38

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28599-9_38

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28598-2

  • Online ISBN: 978-3-030-28599-9

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics